Heartflow raises 2026 revenue forecast, stock jumps 48% after Q2 results

Shares of Heartflow surged on Friday after the medical diagnostics company upgraded its full-year revenue projections. The stock price jumped significantly following the announcement, reflecting investor confidence in Heartflow's growth potential.

Heartflow specializes in using artificial intelligence to transform coronary imaging into personalized 3D heart models. This innovative approach helps doctors detect coronary artery disease, the leading cause of death globally, by providing a non-invasive method to identify plaque and analyze its impact on blood flow. The company's technology is in high demand, underscoring the urgent need for effective heart disease management and detection.

In its second-quarter earnings report, Heartflow revealed a remarkable 48% year-over-year revenue increase, totaling $64.1 million. The company also noted improvements in profitability, with its adjusted gross margin rising to 83.3% from 75.6% in the previous year. While Heartflow is not yet profitable, it reported a narrowed adjusted operating loss of $7.9 million compared to $11.5 million in the same quarter last year. This trend suggests that the company is successfully scaling its operations.

Looking ahead, Heartflow now anticipates full-year revenue growth of 40% to 42%, which translates to projected revenues between $246 million and $250 million in 2026. This marks a significant increase from earlier forecasts of 29% to 32% growth. CEO John Farquhar expressed confidence in the company's long-term profitability, stating that the record gross margins and improved operating leverage demonstrate the scalability of Heartflow's business model. This optimistic outlook is likely to keep investors interested as the company continues to expand its footprint in the medical technology sector.